No Detail Found!

Design, Synthesis, and Computational Studies with ADMET of Novel Cardiovascular Hybrid Drugs

Author(s)
Ashwini A. Bhosale Department of Pharmaceutical Chemistry, Sinhgad Technical Education Society, Sinhgad College of Pharmacy, Vadgaon(Bk), Pune 411041, Maharashtra, India.
Ganesh S. Andhale Department of Pharmaceutical Chemistry, Sinhgad Technical Education Society, Sinhgad College of Pharmacy, Vadgaon(Bk), Pune 411041, Maharashtra, India; Department of Pharmaceutical Chemistry, Alard College of Pharmacy, Marunje, Hinjwadi, Pune-411028, Maharashtra, India.
Rajesh B. Patil Department of Pharmaceutical Chemistry, Sinhgad Technical Education Society, Sinhgad College of Pharmacy, Vadgaon(Bk), Pune 411041, Maharashtra, India.
Abstract
Recently the drug discovery trend has been to design hybrid drug molecules consisting of different pharmacophore groups linked together via spacers. Calcium channel blockers have an important role in the treatment of several cardiovascular diseases. The objective of the present research work is to encompass the strategic design, synthesis, and computational assessment of novel 1,4- dihydropyridine containing calcium channel blocker hybrid containing beta blocker side chain along with NO group as promoting cardiovascular agents as a viable alternative to well-established drugs like Amlodipine, Nifedipine, Felodipine, etc. In this research, we synthesized new 18 cardiovascular hybrid compounds based on structure-activity relationship properties. The 3D crystallographic structure of the calcium channel receptor (6M7H) was obtained from PDB. RCSB and used for docking study. The molecular docking studies were carried out by using the standard option Glide 5.5 in Maestro. In silico molecular docking analysis of all the synthesized compounds, AE1 to AE18, showed good docking scores and remarkable interactions with the essential amino acid residues located within the receptor's binding pocket of 6M7H. In comparison to amlodipine, AE12, AE6, AE8, AE11, AE5, AE16, and AE14 exhibit good scores as well as good binding patterns. AE12 exhibits the highest docking score of -8.455 kcal mol-1. Extensive ADMET profiling and structure-activity relationship (SAR) elucidated favorable pharmacokinetic properties and essential structural modifications influencing antihypertensive effectiveness.
Publication Details
Page(s) 1887-1897
Published Journal: International Journal of Membrane Science and Technology, Volume: 10, Issue: 1, Year: 2023

Request the full text from PASTIC

Keywords
Docking study, ADMET, dihydropyridine, Cardiovascular hybrid drugs
References
Chobanian AV,Bakris GL,Black HR,Cushman WC,Green LA,Izzo Jr JL,Jones DW,Materson BJ,Oparil S,Wright Jr JT,Roccella EJ . .The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. 2003 May, 289(19) : 2560-71.
Mobine HR,Baker AB,Wang L,Wakimoto H,Jacobsen KC,Seidman CE,Seidman JG,Edelman ER . .Pheochromocytoma-induced cardiomyopathy is modulated by the synergistic effects of cell-secreted factors. 2009 Mar, 1(2) : 121-8.
Bhandari SV,Bothara KG,Patil AA,Chitre TS,Sarkate AP,Gore ST,Dangre SC,Khachane CV . .Design, synthesis, and pharmacological screening of novel antihypertensive agents using a hybrid approach. 2009 Jan, 1(1) : 390-400.
Bertram G Katzung,Ka. Basic G Katzung .2003 .clinical pharmacology. EGC, (6) : 166-171.
Christiaans JA,Timmerman H . .Cardiovascular hybrid drugs: a combination of more than one pharmacological property in one single molecule. European journal of pharmaceutical sciences. 1996 Jan, 1(1) : 1-22.
Huang YC,Wu BN,Yeh JL,Chen SJ,Liang JC,Lo YC,Chen J. . .A new aspect of view in synthesizing new type β-adrenoceptor blockers with ancillary antioxidant activities. 2001 Jul, 1(7) : 1739-46.
Liang JC,Yeh JL,Wang CS,Liou SF,Tsai CH,Chen J. . .The new generation dihydropyridine type calcium blockers, bearing 4-phenyl oxypropanolamine, display α-/β-Adrenoceptor antagonist and long-acting antihypertensive activities. 2002 Mar, 1(3) : 719-30.
Boschi D,Cena C,Di Stilo A,Fruttero R,Gasco A . .Nicorandil analogs containing NO-donor furoxans and related furazans. 2000 Jul, 1(7) : 1727-32.
Breschi MC,Calderone V,Digiacomo M,Martelli A,Martinotti E,Minutolo F,Rapposelli S,Balsamo A . .NOsartans: a new class of pharmacodynamic hybrids as cardiovascular drugs. 2004 Nov, 4(23) : 5597-600.
Campiani G,Fiorini I,De Filippis MP,Ciani SM,Garofalo A,Nacci V,Giorgi G,Sega A,Botta M,Chiarini A,Budriesi R . .Cardiovascular characterization of pyrrolo benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers. 1996 Jul, 39(15) : 2922-38.
Mehanna AS,Kim JY . .Design, synthesis, and biological testing of thiosalicylamides as a novel class of calcium channel blockers. 2005 Jul, 1(13) : 4323-31.
Nguyen JT,Velázquez CA . .-dihydropyridines containing a diazen-1-ium-1, 2- diolate nitric oxide donor moiety to study calcium channel antagonist structure-activity relationships and nitric oxide release. 2005 Mar, 1(5) : 1725-38.
Perez M,Pauwels PJ,Pallard-Sigogneau I,Fourrier C,Chopin P,Palmier C,Colovray V,Halazy S. Design . .and synthesis of new potent, silent 5-HT1A antagonists by covalent coupling of aminopropanol derivatives with selective serotonin reuptake inhibitors. 1998 Dec, 1(23) : 3423-8.
Natale NR,Rogers ME,Staples R,Triggle DJ,Rutledge A,Relationships A . .. 1999 Aug, 42(16) : 3087-93.
Yagupolskii LM,Antepohl W,Artunc F,Handrock R,Klebanov BM,Maletina II,Marxen B,Petko KI,Quast U,Vogt A,Weiss C A . .Vasorelaxation by new hybrid compounds containing dihydropyridine and pinacidil-like moieties. 1999 Dec, 42(25) : 5266-71.
Siddiqui AA,Mishra R,Shaharyar M . .Synthesis, characterization and antihypertensive activity of pyridazinone derivatives. 2010 Jun, 1(6) : 2283-90.
Abadi AH,Hegazy GH,El-Zaher AA . .Synthesis of novel 4-substituted-7-trifluoromethylquinoline derivatives with nitric oxide releasing properties and their evaluation as analgesic and anti-inflammatory agents. 2005 Oct, 13(20) : 5759-65.
Rana K,Kaur B,Kumar B . .Synthesis and anti-hypertensive activity of some dihydropyrimidines. 2004 Indian J. Chem. 43B, : 1553-1557.
Chalina EG,Chakarova L,Staneva DT . .Synthesis, antiarrhythmic and hypotensive activity of some novel 1, 3-disubstituted ureas and phenyl N-substituted carbamates. 1998 Dec, 1(12) : 985-90.
Deprez P,Heckmann B,Corbier A,Vevert JP,Fortin M,Guillaume J . .Balanced AT1 and AT2 angiotensin II antagonists. I. New orally active 5-carboxyl imidazolyl biphenyl sulfonylureas. 1995 Nov, 16(22) : 2605-10.
Dylag T.,Zygmunt M.,Maciag D.,Handzlik J.,Bednarski M.,Filipek B.,Kiec K. .2004 .Synthesis and evaluation of in vivo activity of diphenylhydantoin basic derivatives. Eur. J. Med. Chem, 39 : 1013-1027.
Ferrarini PL,Mori C,Primofiore G,Da Settimo A,Breschi MC,Martinotti E,Nieri PA,Ciucci MA,(Z MA . .-iminoethers of 1, 8-naphthyridine. 1990 Jul, 1(6) : 489-96.
Fisher LE,Rosenkranz RP,Clark RD,Muchowski JM,McClelland DL,Michel A,Caroon JM,Galeazzi E,Eglen R,Whiting RL,- RL . .] hexane, a potent, selective, orally active dopamine analog with hypotensive and diuretic activity. 1995 Oct, 19(20) : 2371-6.
Hanft G,Kolassa N. . .Urapidil and some analogs with hypotensive properties show high affinities for 5- hydroxytryptamine (5-HT) binding sites of the 5-HT 1A subtype and α 1-adrenoceptor binding sites. NaunynSchmiedeberg's archives of pharmacology, 336 : 597-601.
Little HJ. . .L-type calcium channel blockers: A potential novel therapeutic approach to drug dependence. 2021 Oct, 1(4) : 1298-325.
Israili ZH,Hernández-Hernández R,Valasco M. . .The future of antihypertensive treatment. 2007 Mar, 1(2) : 121-34.
Kheli S.,Leclerer G.,- G. .1995 .-dioxides on rat aorta. Bioorg. Med. Chem, 3(1) : 495-503.
Kato T,Ozaki T,Tamura K,Suzuki Y,Akima M,Ohi N. . .Novel calcium antagonists with both calcium overload inhibition and antioxidant activity. 1. 2-(3, 5-di-tert-butyl-4-hydroxyphenyl)-3-(aminopropyl)thiazolidinones. 1998 Oct, 41(22) : 4309-16.
Smith R.,Timmermans W.,Pieter B.,A. B.,Descovery Drug .1996 .Berger's Medicinal Chemistry. , : 265-314.
Acharjee S,Bothara KG,Bhandari SV,Maity TK . .Design, synthesis and pharmacological screening of hybrid molecules as antihypertensives. Medicinal Chemistry Research, 20 : 705-13.
Visentin S,Rolando B,Di Stilo A,Fruttero R,Novara M,Carbone E,Roussel C,Vanthuyne N,Gasco A . .New 1, 4-dihydropyridines endowed with NO-donor and calcium channel agonist properties. 2004 May, 6(10) : 2688-93.
Waring WS,Webb DJ . .Is there a need for novel antihypertensive therapies Drug Discovery Today: Therapeutic Strategies. 2004 Oct, 1(2) : 143-8.
Takkar P,Singh B,Pani B,Kumar R .2023 .Design, synthesis and in silico evaluation of newer 1, 4-dihydropyridine based amlodipine bio-isosteres as promising antihypertensive agents. RSC advances, 13(48) : 34239-48.
Trott O,Olson AJ . .AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. 2010 Jan, 30(2) : 455-61.
Bowers KJ,Chow E,Xu H,Dror RO,Eastwood MP,Gregersen BA,Klepeis JL,Kolossvary I,Moraes MA,Sacerdoti FD,Salmon JK . .Scalable algorithms for molecular dynamics simulations on commodity clusters. In Proceedings of the 2006 ACM/IEEE Conference on Supercomputing 2006 Nov, 11 : 84-es.
Doherty W,Adler N,Knox A,Nolan D,McGouran J,Nikalje AP,Lokwani D,Sarkate A,Evans P . .Synthesis and evaluation of 1, 2, 3‐triazole‐containing vinyl and allyl sulfones as anti‐trypanosomal agents. 2017 Jan, 3(2017) : 175-85.
Friesner RA,Banks JL,Murphy RB,Halgren TA,Klicic JJ,Mainz DT,Repasky MP,Knoll EH,Shelley M,Perry JK,Shaw DE . .Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. 2004 Mar, 25(7) : 1739-49.
Karnik KS,Narula IS,Sarkate AP,Wakte PS . .Auto QSAR fast approach for creation and application of QSAR models through automation. 2020 May, 22(19) : 5756-62.
0

Citations

0

Downloads

28

Views